Vinay Prasad has recently taken on three significant roles within the Food and Drug Administration, solidifying his position as a key advisor to Commissioner Marty Makary. In an internal memo obtained by STAT, it was revealed that Prasad will now serve as the agency’s chief medical and scientific officer, as well as leading the center responsible for regulating vaccines, gene therapies, and the blood supply. This consolidation of roles is a departure from the traditional setup, where the chief scientist and chief medical officer were distinct positions.
Makary, in the memo announcing the news to staff, highlighted Prasad’s new role as a trusted advisor to the FDA Commissioner and other senior officials on a range of medical and scientific issues impacting regulatory science and public health. The agency has not yet responded to requests for comment on this development.
This article is exclusive to STAT+ subscribers. By unlocking this article, subscribers gain access to in-depth analysis, newsletters, premium events, and news alerts. To view this content and more, individuals can log in to their account or explore the various subscription plans available on the platform.
The integration of Prasad into these critical roles signifies a strategic move by the FDA to enhance its medical and scientific expertise under Commissioner Makary’s leadership. With his extensive background and experience in healthcare and research, Prasad is well-positioned to provide valuable insights and guidance in shaping the agency’s regulatory decisions in the ever-evolving landscape of public health.
